Bearish
Pfizer's stock drops 3% after CFO's surprise departure, despite guidance
Pfizer's stock declined by 3% following the unexpected announcement of CFO Dave Denton's resignation, effective August 15, 2026. Despite this, the company reaffirmed its 2026 financial outlook, maintaining revenue expectations of $59.5 billion to $62.5 billion and adjusted earnings per share between $2.80 and $3.00.
Key points
- CFO Dave Denton resigns unexpectedly, effective August 15, 2026.
- Pfizer reaffirms 2026 financial guidance, maintaining revenue and earnings projections.
Sources
AI-generated from public news sources. Not financial advice.
